The outlook of companies tied to blockbuster drugs like Viagra presents a nuanced investment scenario . While the initial surge of copyright, fueled by Viagra's remarkable popularity, generated substantial profits , the loss of exclusivity in key regions has introduced substantial uncertainty . Investors are now facing the impact of rival medicatio